Silicon Kidney LLC

Silicon Kidney LLC is a self-certified small disadvantaged business registered to receive federal awards since January 2011. The company specializes in developing advanced biomedical technologies, particularly focusing on innovative solutions for kidney disease treatment and diabetes management. Silicon Kidney LLC's core expertise lies in the development and application of silicon nanopore membrane technology for various medical applications. Through federal grant awards, the company provides cutting-edge research and development services to address critical health challenges, particularly in the areas of renal replacement therapy and bioartificial organ development.

Silicon Kidney LLC has received multiple federal grant awards from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to support its groundbreaking research. The company is developing an Intracorporeal Hemodialysis System (IHEMO) to address mortality disparities among rural and remote end-stage kidney disease patients, focusing on creating a zeolite-based external dialysate system integrated with an implanted hemocartridge. Additionally, Silicon Kidney LLC is working on an anticoagulant-free blood filter using silicon nanopore membrane technology for continuous renal replacement therapy in acute kidney injury patients. The company is also involved in developing a high oxygen capacity cell scaffold for an intravascular bioartificial pancreas. As a sub-awardee to the University of California, San Francisco, Silicon Kidney LLC provides specialized silicon nanopore membranes for biomedical device development, leveraging its expertise in MEMS technology and membrane fabrication. These projects demonstrate the company's commitment to advancing medical technologies that can significantly improve patient outcomes and quality of life for those with kidney and pancreatic disorders.